The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer: a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results.
Future Oncol
; 20(1): 5-16, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-37916267
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Pyridines
/
Breast Neoplasms
Limits:
Female
/
Humans
Language:
En
Journal:
Future Oncol
Year:
2024
Type:
Article
Affiliation country:
United States